1.
Vittrup I, Thein D, Thomsen SF, Egeberg A, Thyssen JP. Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study. Acta Derm Venereol [Internet]. 2024 Jan. 22 [cited 2024 Aug. 24];104:adv18638. Available from: https://medicaljournalssweden.se/actadv/article/view/18638